Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms.
Yokokawa A, Kaneko S, Endo S, Minowa Y, Ayukawa H, Hirano R, Nagashima F, Naruge D, Okano N, Kobayashi T, Kawai K, Furuse J, Furuta T, Shibasaki H. Yokokawa A, et al. Among authors: naruge d. Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):317-324. doi: 10.1007/s13318-021-00675-3. Epub 2021 Feb 23. Eur J Drug Metab Pharmacokinet. 2021. PMID: 33619631
Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival.
Kasuga A, Okano N, Naruge D, Kitamura H, Takasu A, Nagashima F, Furuse J. Kasuga A, et al. Among authors: naruge d. Cancer Chemother Pharmacol. 2015 Mar;75(3):457-64. doi: 10.1007/s00280-014-2665-8. Epub 2014 Dec 30. Cancer Chemother Pharmacol. 2015. PMID: 25547407
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
Kasuga A, Nakagawa K, Nagashima F, Shimizu T, Naruge D, Nishina S, Kitamura H, Kurata T, Takasu A, Fujisaka Y, Okamoto W, Nishimura Y, Mukaiyama A, Matsushita H, Furuse J. Kasuga A, et al. Among authors: naruge d. Invest New Drugs. 2015 Oct;33(5):1058-67. doi: 10.1007/s10637-015-0270-2. Epub 2015 Aug 12. Invest New Drugs. 2015. PMID: 26259955 Clinical Trial.
[Geriatric Oncology].
Maeno S, Nagashima F, Naruge D, Okano N, Kawai K, Kobayashi T, Kitamura H, Furuse J. Maeno S, et al. Among authors: naruge d. Gan To Kagaku Ryoho. 2017 Feb;44(2):97-101. Gan To Kagaku Ryoho. 2017. PMID: 28223666 Review. Japanese.
18 results